ATE253647T1 - Verfahren und zusammensetzung zur detektion pathogener zustände - Google Patents

Verfahren und zusammensetzung zur detektion pathogener zustände

Info

Publication number
ATE253647T1
ATE253647T1 AT00962576T AT00962576T ATE253647T1 AT E253647 T1 ATE253647 T1 AT E253647T1 AT 00962576 T AT00962576 T AT 00962576T AT 00962576 T AT00962576 T AT 00962576T AT E253647 T1 ATE253647 T1 AT E253647T1
Authority
AT
Austria
Prior art keywords
nucleic acid
disease
characteristic
blood cells
library
Prior art date
Application number
AT00962576T
Other languages
English (en)
Inventor
Bruno Tocque
Laurent Bracco
Fabien Schweighoffer
Original Assignee
Exonhit Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exonhit Therapeutics Sa filed Critical Exonhit Therapeutics Sa
Application granted granted Critical
Publication of ATE253647T1 publication Critical patent/ATE253647T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
AT00962576T 1999-09-16 2000-09-05 Verfahren und zusammensetzung zur detektion pathogener zustände ATE253647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911563A FR2798673B1 (fr) 1999-09-16 1999-09-16 Methodes et compositions pour la detection d'evenements pathologiques
PCT/FR2000/002439 WO2001020027A1 (fr) 1999-09-16 2000-09-05 Methodes et compositions pour la detection d'evenements pathologiques

Publications (1)

Publication Number Publication Date
ATE253647T1 true ATE253647T1 (de) 2003-11-15

Family

ID=9549896

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00962576T ATE253647T1 (de) 1999-09-16 2000-09-05 Verfahren und zusammensetzung zur detektion pathogener zustände
AT03017827T ATE319860T1 (de) 1999-09-16 2000-09-05 Verfahren und zusammensetzungen für die detektion pathologischer ereignisse

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03017827T ATE319860T1 (de) 1999-09-16 2000-09-05 Verfahren und zusammensetzungen für die detektion pathologischer ereignisse

Country Status (14)

Country Link
US (2) US6372432B1 (de)
EP (2) EP1382693B1 (de)
JP (1) JP2003515317A (de)
AT (2) ATE253647T1 (de)
AU (1) AU774263B2 (de)
CA (1) CA2383880C (de)
CY (1) CY1105322T1 (de)
DE (2) DE60026624T2 (de)
DK (2) DK1382693T3 (de)
ES (2) ES2256629T3 (de)
FR (1) FR2798673B1 (de)
IL (2) IL148613A0 (de)
PT (2) PT1198595E (de)
WO (1) WO2001020027A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261808B1 (en) * 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
US20030165931A1 (en) * 1998-03-11 2003-09-04 Bruno Tocque Qualitative differential screening
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
FR2798392B1 (fr) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa Marqueurs genetiques de la toxicite, preparation et utilisations
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US7361488B2 (en) * 2000-02-07 2008-04-22 Illumina, Inc. Nucleic acid detection methods using universal priming
EP1329506A1 (de) * 2002-01-18 2003-07-23 Cypro S.A. Verfahren zur Quantifizierung vom RNA Niveau in vivo
ES2375724T3 (es) * 2002-09-27 2012-03-05 The General Hospital Corporation Dispositivo microflu�?dico para seperación de células y sus usos.
EP1636379A2 (de) * 2003-06-26 2006-03-22 Exonhit Therapeutics S.A. Prostata-spezifische gene und deren verwendung als ziele für die therapie und diagnose von prostatakrebs
WO2005017186A2 (en) * 2003-08-08 2005-02-24 Thomas Jefferson University Method for rapid identification of alternative splicing
AU2005218622A1 (en) * 2004-03-03 2005-09-15 Living Microsystems Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US20070026414A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026413A1 (en) * 2005-07-29 2007-02-01 Mehmet Toner Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026415A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070196820A1 (en) * 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US20070026416A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059683A1 (en) * 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
US20070059718A1 (en) * 2005-09-15 2007-03-15 Mehmet Toner Systems and methods for enrichment of analytes
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
EP2589668A1 (de) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten
WO2008111990A1 (en) * 2006-06-14 2008-09-18 Cellpoint Diagnostics, Inc. Rare cell analysis using sample splitting and dna tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US9946887B2 (en) 2012-06-04 2018-04-17 Nokia Technologies Oy Method and apparatus for determining privacy policy based on data and associated values

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5985549A (en) * 1985-10-22 1999-11-16 University Of Massachusetts Non-isotopic in-situ hybridization method for detection of nucleic acids
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6309822B1 (en) * 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5215882A (en) * 1989-11-30 1993-06-01 Ortho Diagnostic Systems, Inc. Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
US5521297A (en) * 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5529925A (en) * 1993-12-03 1996-06-25 St. Jude Children's Research Hospital Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US5484702A (en) * 1994-01-27 1996-01-16 Research Foundation Of The State University Of New York At Buffalo Method for preselecting recombinant clones containing a specific nucleic acid sequence and subsequent transformation with preselected clones
US5679541A (en) * 1994-02-14 1997-10-21 California Institute Of Technology Programmed cell death antagonist protein
PH31414A (en) * 1994-02-24 1998-10-29 Boehringer Ingelheim Int Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
EP0701277B1 (de) * 1994-05-27 2008-02-27 Texas Instruments Incorporated Verbindungsverfahren mit Benutzung eines porösen Isolators zur Reduzierung der Kapazitäten zwischen Leiterbahnen
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5767258A (en) * 1995-05-12 1998-06-16 The Johns Hopkins University School Of Medicine Cell cycle regulatory gene
US5922535A (en) * 1995-11-07 1999-07-13 Huo; Li Identifying sequence differences in nucleic acid populations
US6268170B1 (en) * 1995-11-14 2001-07-31 Northwestern University α-Tocopherol transport protein: compositions and methods
EP0880598A4 (de) * 1996-01-23 2005-02-23 Affymetrix Inc Verfahren zur analyse von nukleinsäure
EP0791660A1 (de) * 1996-02-22 1997-08-27 Smithkline Beecham Corporation Neuer diagnostischer Marker für Spleissvarianten von Genen, verbunden mit neurologischen Funktionen
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
US20030165931A1 (en) * 1998-03-11 2003-09-04 Bruno Tocque Qualitative differential screening
EP1736554B1 (de) * 1996-05-29 2013-10-09 Cornell Research Foundation, Inc. Bestimmung von Unterschieden in der Nukleinsäuresequenz mittels einer Kombination von Ligasebestimmung und Polymerasekettenreaktion
KR20000048820A (ko) * 1996-10-01 2000-07-25 게론 코포레이션 텔로머라제 역전사 효소
US6475789B1 (en) * 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US5858671A (en) * 1996-11-01 1999-01-12 The University Of Iowa Research Foundation Iterative and regenerative DNA sequencing method
ATE234674T1 (de) * 1996-11-14 2003-04-15 Affymetrix Inc Chemische amplifizierung zur synthese von musterordnungen
US6060240A (en) * 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
US6303301B1 (en) * 1997-01-13 2001-10-16 Affymetrix, Inc. Expression monitoring for gene function identification
DE69825601T2 (de) * 1997-02-12 2005-04-28 Chan, Eugene Y, Brookline Verfahren zur analyse von polymeren
US6951924B2 (en) * 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
DE69833758T2 (de) * 1997-06-13 2006-08-31 Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara Verfahren zur erkennung von genpolymorphismen und allelexpression unter verwendung von sondenchips
CA2225187A1 (en) * 1997-07-14 1999-01-14 Universite D'ottawa/ University Of Ottawa Xaf genes and polypeptides: methods and reagents for modulating apoptosis
US6849400B1 (en) * 1997-07-23 2005-02-01 Gen-Probe Incorporated Methods for detecting and measuring spliced nucleic acids
IL121806A0 (en) * 1997-09-21 1998-02-22 Compugen Ltd Method and apparatus for MRNA assembly
JPH11262621A (ja) * 1998-03-17 1999-09-28 Ebara Corp 除湿空調装置
US6699659B2 (en) * 1998-06-01 2004-03-02 Affymetrix, Inc. Products and methods for analyzing nucleic acids including identification of substitutions, insertions and deletions
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
US6160105A (en) * 1998-10-13 2000-12-12 Incyte Pharmaceuticals, Inc. Monitoring toxicological responses
US6368794B1 (en) * 1999-01-15 2002-04-09 Incyte Genomics, Inc. Detection of altered expression of genes regulating cell proliferation
FR2798392B1 (fr) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa Marqueurs genetiques de la toxicite, preparation et utilisations
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US6713257B2 (en) * 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays
CA2450577A1 (en) * 2001-06-21 2003-01-03 Diversa Corporation Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes
JP2007512811A (ja) * 2003-11-10 2007-05-24 インベスチゲン， インコーポレイテッド 検出のための核酸を調製する方法

Also Published As

Publication number Publication date
US6372432B1 (en) 2002-04-16
EP1198595A1 (de) 2002-04-24
DK1198595T3 (da) 2004-03-15
PT1198595E (pt) 2004-03-31
CY1105322T1 (el) 2010-03-03
JP2003515317A (ja) 2003-05-07
IL148613A0 (en) 2002-09-12
WO2001020027A1 (fr) 2001-03-22
ATE319860T1 (de) 2006-03-15
EP1382693A1 (de) 2004-01-21
US20090264301A1 (en) 2009-10-22
ES2256629T3 (es) 2006-07-16
EP1198595B1 (de) 2003-11-05
CA2383880C (fr) 2012-08-28
AU7425200A (en) 2001-04-17
DE60026624D1 (de) 2006-05-04
DE60026624T2 (de) 2006-12-21
FR2798673A1 (fr) 2001-03-23
FR2798673B1 (fr) 2004-05-28
EP1382693B1 (de) 2006-03-08
AU774263B2 (en) 2004-06-24
ES2209984T3 (es) 2004-07-01
IL187097A (en) 2010-04-15
PT1382693E (pt) 2006-07-31
DE60006392D1 (de) 2003-12-11
DK1382693T3 (da) 2006-07-17
CA2383880A1 (fr) 2001-03-22
DE60006392T2 (de) 2004-09-02

Similar Documents

Publication Publication Date Title
ATE253647T1 (de) Verfahren und zusammensetzung zur detektion pathogener zustände
Kahn et al. Gene expression profiling in an in vitro model of angiogenesis
GB2374929A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
WO2003035895A3 (en) Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
WO2004032621A3 (en) Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence
WO2002074911A3 (en) Identification of gene expression alterations underlying the aging process in mammals
Strehlow et al. A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma
CN100371459C (zh) 细胞角蛋白19(CK19)mRNA荧光定量RT-PCR检测试剂盒
CN107727621A (zh) 一种无酶标记DNA逻辑体系检测miRNA的方法
JP2000509250A (ja) 部位特定ガン転移巣発生に伴う遺伝子識別のための免疫性磁気細胞分離
CN107475379A (zh) 一种用于肿瘤诊断与预后检测的分子标志物及其检测引物和试剂盒
US20190192698A1 (en) A method for obtaining indicator signals from a cell
CN110205376A (zh) 硅基探针材料、硅基探针及其制备方法和应用
Watson et al. Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution
WO2019057367A1 (en) ENHANCED DETECTION OF ANTICOAGULANTS IN ORGANIC LIQUIDS
CN108070661A (zh) Kras基因检测试剂盒及检测方法
Azuma et al. Anin VitroSystem for Identifying Agents Capable of Changing Serum Lipoprotein (a) Concentration by Regulating the Transcriptional Activity of the Apolipoprotein (a) Gene Promoter
DE60237406D1 (de) Aus einem Neuroblastom isolierte Nukleinsäuren
FR2786787B1 (fr) Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques
CN108384848A (zh) 血清中circ_0021132作为深静脉血栓形成诊断标志物的应用
MX9700502A (es) Marcador de cancer de pulmon.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1198595

Country of ref document: EP